Insight Molecular Diagnostics Inc. (IMDX)

IMDX Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for IMDX stock has a target of 4.25, which predicts a -25.89% decrease from the current stock price of 5.74.

Price Target: $4.25 (-25.89%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.25	$4.25	$4.25	$4.25
Change	-25.89%	-25.89%	-25.89%	-25.89%

* Price targets were last updated on Aug 18, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for IMDX is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25
Strong Buy	1	1
Buy	0	0
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mike Matson Needham	Needham	Strong Buy Reiterates $4.25	Strong Buy	Reiterates	$4.25	-25.89%	Aug 18, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.34M

Increased by 77.62%

from 1.88M

Revenue Next Year

3.65M

Increased by 9.16%

from 3.34M

EPS This Year

-0.99

from -4.66

EPS Next Year

-0.80

from -0.99

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.22M	2.20M	958.00K	1.50M	1.88M	3.34M	3.65M
Revenue Growth	-	80.76%	-56.42%	56.89%	25.15%	77.62%	9.16%
EPS	-9.14	-14.42	-13.25	-3.75	-4.66	-0.99	-0.80
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	3.8M	5.4M
Avg	3.3M	3.6M
Low	3.0M	1.1M

Revenue Growth

Revenue Growth	2025	2026	2027
High	101.0%	60.3%
Avg	77.6%	9.2%
Low	61.5%	-67.7%

EPS Forecast

EPS	2025	2026	2027
High	-0.96	-0.74
Avg	-0.99	-0.80
Low	-1.01	-0.87

EPS Growth

EPS Growth	2025	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.